Home LiteratureArticle Details
PMID: 7004190 Published · ppublish English Case Reports Journal Article Research Support, U.S. Gov't, P.H.S.

Three metronidazole-resistant strains of Trichomonas vaginalis from the United States.

American journal of obstetrics and gynecology ·Vol. 138 ·No. 7 Pt 1 ·1980-12-01 ·Pages 808-12

Müller M, Meingassner JG, Miller WA, Ledger WJ

Abstract

Trichomonas vaginalis isolates were obtained in the United States from three women with trichomoniasis refractory to routine treatment with metronidazole. Cure was obtained in these cases with increased dosage of metronidazole. In experimental mouse infections, all three strains showed a significantly (about 10 to 20 times) lower susceptibility to metronidazole than did a number of control strains. In vitro, the lowered susceptibility could be detected only in an aerobic assay but not in the routine anaerobic assay. The conclusion is that T. vaginalis strains with lowered metronidazole susceptibility do exist. Such strains might be responsible for a certain, but as yet entirely unknown, number of failures in routine metronidazole therapy of human trichomoniasis.

MeSH Terms
Adult Animals Drug Resistance, Microbial Female Humans Metronidazole/pharmacology,therapeutic use Mice Microbiological Techniques Trichomonas Vaginitis/drug therapy Trichomonas vaginalis/drug effects
Chemicals
Metronidazole
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Müller M
Meingassner J G
Miller W A
Ledger W J
Article Info
Journal
American journal of obstetrics and gynecology
Abbr.
Am J Obstet Gynecol
ISSN
0002-9378
Published
1980-12-01
Pages
808-12
Language
English
Region
United States
NLM ID
0370476
Subset
IM
Grants
NIAID NIH HHS · AI 11942 · United States
NIAID NIH HHS · AI 12932 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]